[
    [
        {
            "time": "",
            "original_text": "安图生物：郑州德迈药业有限公司与上海安图生物有限公司主要从事的是医药相关领域，未来不会与上市公司之间产生利益冲突",
            "features": {
                "keywords": [
                    "安图生物",
                    "郑州德迈药业",
                    "上海安图生物",
                    "医药相关领域",
                    "利益冲突"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "安图生物：郑州德迈药业有限公司与上海安图生物有限公司主要从事的是医药相关领域，未来不会与上市公司之间产生利益冲突",
                "Correlation": 8,
                "Sentiment": 6,
                "Importance": 5,
                "Impact": 4,
                "Duration": 5,
                "Entity_Density": 7,
                "Market_Scope": 3,
                "Time_Proximity": 6,
                "Headline_Structure": 5,
                "Source_Recency": 7
            }
        }
    ]
]